# Glucofit

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glucofit

- Industry: Medical Devices & Equipment
- Headquarters: Seoul, South Korea
- Website: https://glucofit.co.kr/
- Total disclosed funding: $0.2M
- Latest round: Seed (Dec 5, 2023)
- Investors on record: 2

## About

Founded in 2022 and based in Seoul, South Korea, Ransik Co., Ltd., dba Glucofit is a blood sugar management solution based on artificial intelligence technology. In February 2024, Glucofit raised KRW 1.2 billion in pre-series A funding led by BonAngels, including Capstone Partners, Infobank, and the Banks Foundation for Young Entrepreneurs. As of 2024, the company is led by its CEO, Yang Hyeok-yong.

The company provides GlucoFit, which is a blood sugar management program designed to empower individuals to take control of their health by leveraging technology and medical expertise. The firm employs a non-blood-sampling continuous blood glucose meter, providing real-time insights into blood sugar levels conveniently through a smartphone interface. GlucoFit offers daily reports, hyper-personalized management strategies, and access to professional coaching from doctors-turned-coaches.

The organization plans to use the February 2024 funding to secure new customers and enhance customer satisfaction by focusing on service advancement.

## Funding rounds

- Seed, Dec 5, 2023, $0.2M — Infobank
- Seed, Jan 31, 2023 — Primer

## Investors

- Primer (https://capitalatlas.ai/funds/primer) — Seed
- Infobank (https://capitalatlas.ai/funds/infobank) — Seed